{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-269417","form_type":"8-K","ticker":null,"cik":"0001538210","company_name":"NexImmune, Inc.","filed_at":"2023-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.424438+00:00","generated_at":"2026-06-09T00:10:45.537305+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"NexImmune regains Nasdaq minimum bid price compliance; delisting notice resolved","bullets":["Received delisting notice on Oct 27, 2023 after second 180-day compliance period expired Oct 23.","Regained compliance per Nasdaq notice dated Nov 1, 2023 following 1-for-25 reverse stock split effective Oct 18.","Closing bid price has remained above $1.00 since reverse split; Nasdaq listing matter closed.","Common stock continues trading on Nasdaq Capital Market under ticker NEXI."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-269417","json":"https://secwatch.observer/filing/0001193125-23-269417.json","markdown":"https://secwatch.observer/filing/0001193125-23-269417.md","text":"https://secwatch.observer/filing/0001193125-23-269417.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1538210/000119312523269417/0001193125-23-269417-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1538210/000119312523269417/d576516d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T00:10:45.537305+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f4ad005c2a3a6f21c2e6ab4a800d794f9431cff1","claim":"NexImmune, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"November 1, 2023, NexImmune, Inc. (the “Company”) received a notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has regained compliance with the minimum closing bid price requirement for continued listing on The Nasdaq Capital Market (the “Capital Market”) under Nasdaq Listing Rule 5550(a)(2) (the “Rule”), and as a result, the Company’s common stock continues to trade on the Capital Market and the matter is now closed. Previously, on October 27, 2023, the Company received a notice from Nasdaq informing the Company that Nasd","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1538210/000119312523269417/0001193125-23-269417-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"compliance regained"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}